Structures published

Total: 18

6-Bromo-3-(5-bromohexyl)-2-[4-(dimethylamino)phenyl]-3H-imidazo[4,5-b]pyridine

C₂₀H₂₄Br₂N₄

Jabri, Zainab Sebbar, Nada Kheira Hökelek, Tuncer Mague, Joel T.Sabir, Safia Rodi, Youssef Kandri Misbahi, Khalid

Acta Crystallographica Section E (2020) 76, 8 1234-1238

a=8.1488(11)Å b=11.2243(15)Å c=12.6378(17)Å

α=64.049(2)° β=74.184(2)° γ=86.067(2)°

3-{[3-(4-Chlorophenyl)-4,5-dihydro-1,2-oxazol-5-yl]methyl}-1,5-dimethyl- 1H-1,5-benzodiazepine-2,4(3H,5H)-dione

C₂₁H₂₀ClN₃O₃

Dardouri, Rachida Rodi, Youssef Kandri Ladeira, Sonia Essassi, El Mokhtar Ng, Seik Weng

Acta Crystallographica Section E (2011) 67, 3 o720

a=8.18210(10)Å b=9.07410(10)Å c=13.3792(2)Å

α=79.7480(10)° β=80.1420(10)° γ=85.9100(10)°

6-Bromo-3-methyl-1H-imidazo[4,5-b]pyridin-2(3H)-one

C₇H₆BrN₃O

Ghacham, Hend Bel Rodi, Youssef Kandri Capet, Frédéric Essassi, El Mokhtar Ng, Seik Weng

Acta Crystallographica Section E (2010) 66, 5 o1080

a=4.41510(10)Å b=9.6004(2)Å c=10.5330(3)Å

α=116.2480(10)° β=93.074(2)° γ=91.6870(10)°

8-Bromo-3,4-dihydro-2H1,3-thiazino[2,3:2',1']imidazo[5',4'- b]pyridine

C₉H₈BrN₃S

Ghacham, Hend Bel Rodi, Youssef Kandri Capet, Frédéric Essassi, El Mokhtar Ng, Seik Weng

Acta Crystallographica Section E (2010) 66, 5 o1079

a=20.2738(3)Å b=13.2786(2)Å c=7.31690(10)Å

α=90.00° β=102.1930(10)° γ=90.00°

3-Benzyl-6-bromo-2-(2-furyl)-3H-imidazo[4,5-b]pyridine

C₁₇H₁₂BrN₃O

Ouzidan, Younès Rodi, Youssef Kandri Zouihri, Hafid Essassi, El Mokhtar Ng, Seik Weng

Acta Crystallographica Section E (2010) 66, 7 o1874

a=15.8422(3)Å b=5.47470(10)Å c=18.4243(3)Å

α=90.00° β=111.5090(10)° γ=90.00°

4-Allyl-6-bromo-2-phenyl-4H-imidazo[4,5-b]pyridine monohydrate

C₁₅H₁₂BrN_3,H₂O

Ouzidan, Younès Rodi, Youssef Kandri Zouihri, Hafid Essassi, El Mokhtar Ng, Seik Weng

Acta Crystallographica Section E (2010) 66, 8 o1903

a=7.43630(10)Å b=9.42380(10)Å c=11.0829(2)Å

α=68.0760(10)° β=74.6370(10)° γ=79.7360(10)°

6-Bromo-1,3-dimethyl-1H-imidazo[4,5-b]pyridin-2(3H)-one

C₈H₈BrN₃O

Dahmani, Siham Rodi, Youssef Kandri Zouihri, Hafid Essassi, El Mokhtar Ng, Seik Weng

Acta Crystallographica Section E (2010) 66, 8 o1904

a=21.7981(4)Å b=3.99290(10)Å c=20.6636(3)Å

α=90.00° β=95.3980(10)° γ=90.00°

1,3,3,5-Tetramethyl-1H-1,5-benzodiazepine-2,4(3H,5H)-dione

C₁₃H₁₆N₂O₂

Dardouri, Rachida Rodi, Youssef Kandri Saffon, Natalie Essassi, El Mokhtar Ng, Seik Weng

Acta Crystallographica Section E (2011) 67, 4 o783

a=7.51120(10)Å b=10.1731(2)Å c=15.8697(3)Å

α=90.00° β=103.6750(10)° γ=90.00°

3-Benzoyl-1,5-dimethyl-1H-1,5-benzodiazepine-2,4(3H,5H)-\ dione

C₁₈H₁₆N₂O₃

Dardouri, Rachida Rodi, Youssef Kandri Ladeira, Sonia Essassi, El Mokhtar Ng, Seik Weng

Acta Crystallographica Section E (2011) 67, 4 o849

a=7.78270(10)Å b=23.7595(4)Å c=8.6315(2)Å

α=90.00° β=105.6140(10)° γ=90.00°

1,3-Dibenzyl-5-chloro-1H-benzimidazol-2(3H)-one

C₂₁H₁₇ClN₂O

Dardouri, Rachida Rodi, Youssef Kandri Ladeira, Sonia Essassi, El Mokhtar Ng, Seik Weng

Acta Crystallographica Section E (2011) 67, 8 o2136

a=11.0380(4)Å b=9.2863(3)Å c=33.2679(13)Å

α=90.00° β=92.297(2)° γ=90.00°

1,3-Bis[3-(1,3-dioxoisoindolin-2-yl)propyl]-1H- anthra[1,2-d]imidazole-2,6,11(3H)-trione

C₃₇H₂₆N₄O₇

Afrakssou, Zahra Rodi, Youssef Kandri Capet, Frédéric Essassi, El Mokhtar Ng, Seik Weng

Acta Crystallographica Section E (2011) 67, 8 o2137

a=8.4278(2)Å b=13.1258(3)Å c=13.7966(3)Å

α=94.3590(10)° β=92.4720(10)° γ=105.3510(10)°

3-Hexadecyl-1,5-dimethyl-1H-1,5-benzodiazepine- 2,4(3H,5H)-dione

C₂₇H₄₄N₂O₂

Dardouri, Rachida Rodi, Youssef Kandri Ladeira, Sonia Essassi, El Mokhtar Ng, Seik Weng

Acta Crystallographica Section E (2011) 67, 5 o1155

a=8.14260(10)Å b=36.2705(5)Å c=9.40900(10)Å

α=90.00° β=114.6110(10)° γ=90.00°

Di-tert-butyl 2,6,11-trioxo-2,3-dihydro-1H-anthra[1,2-d]imidazole-1,3-diacetate

C₂₇H₂₈N₂O₇

Afrakssou, Zahra Rodi, Yousef Kandri Saffon, Natalie Essassi, El Mokhtar Ng, Seik Weng

Acta Crystallographica Section E (2011) 67, 7 o1730

a=19.5785(4)Å b=13.0330(3)Å c=9.9269(2)Å

α=90.00° β=90.5830(10)° γ=90.00°

3-{[3-(4-Methoxyphenyl)-4,5-dihydro-1,2-oxazol-5-yl]methyl}- 1,5-dimethyl-1H-1,5-benzodiazepine-2,4(3H,5H)-dione

C₂₂H₂₃N₃O₄

Dardouri, Rachida Rodi, Yousef Kandri Saffon, Natalie Essassi, El Mokhtar Ng, Seik Weng

Acta Crystallographica Section E (2011) 67, 7 o1729

a=28.0041(5)Å b=15.4644(3)Å c=9.0350(2)Å

α=90.00° β=93.2350(10)° γ=90.00°

5-Chloro-1-[(E)-3-(dimethylamino)acryloyl]-3-methyl-1H- benzimidazol-2(3H)-one--6-chloro-1-[(E)- 3-(dimethylamino)acryloyl]-3-methyl-1H-benzimidazol-2(3H)-one (4/1)

C₁₃H₁₄ClN₃O₂

Dardouri, Rachida Rodi, Yousef Kandri Saffon, Natalie Essassi, El Mokhtar Ng, Seik Weng

Acta Crystallographica Section E (2011) 67, 7 o1853

a=7.3145(2)Å b=14.2903(3)Å c=25.1512(6)Å

α=90.00° β=90.00° γ=90.00°

4-(1,3-Benzothiazol-2-yl)-1,5-dimethyl-2-phenyl-1H-pyrazol- 3(2H)-one

C₁₈H₁₅N₃OS

Chakib, Imane Zerzouf, Abdelfettah Rodi, Youssef Kandri Essassi, El Mokhtar Ng, Seik Weng

Acta Crystallographica Section E (2011) 67, 10 o2700

a=8.7428(2)Å b=25.7551(5)Å c=6.96600(10)Å

α=90.00° β=97.4600(10)° γ=90.00°

1,3-Diallyl-1H-anthra[1,2-d]imidazole-2,6,11(3H)-trione

C₂₁H₁₆N₂O₃

Afrakssou, Zahra Rodi, Youssef Kandri Zouihri, Hafid Essassi, El Mokhtar Ng, Seik Weng

Acta Crystallographica Section E (2010) 66, 7 o1851

a=7.8539(2)Å b=11.5822(3)Å c=18.1455(4)Å

α=90.00° β=93.5370(10)° γ=90.00°

1,3-Bis(naphthalen-2-ylmethyl)-1H-anthra[1,2-d]imidazole- 2,6,11(3H)-trione

C₃₇H₂₄N₂O₃

Afrakssou, Zahra Rodi, Youssef Kandri Capet, Frédéric Essassi, El Mokhtar Ng, Seik Weng

Acta Crystallographica Section E (2011) 67, 8 o2138

a=8.09010(10)Å b=12.8226(2)Å c=26.1472(4)Å

α=90.00° β=90.00° γ=90.00°

Structures by: Rodi Y. K.

Total: 18

6-Bromo-3-(5-bromohexyl)-2-[4-(dimethylamino)phenyl]-3<i>H</i>-imidazo[4,5-<i>b</i>]pyridine

3-{[3-(4-Chlorophenyl)-4,5-dihydro-1,2-oxazol-5-yl]methyl}-1,5-dimethyl- 1<i>H</i>-1,5-benzodiazepine-2,4(3<i>H</i>,5<i>H</i>)-dione

6-Bromo-3-methyl-1<i>H</i>-imidazo[4,5-<i>b</i>]pyridin-2(3<i>H</i>)-one

8-Bromo-3,4-dihydro-2<i>H</i>1,3-thiazino[2,3:2',1']imidazo[5',4'- <i>b</i>]pyridine

3-Benzyl-6-bromo-2-(2-furyl)-3<i>H</i>-imidazo[4,5-<i>b</i>]pyridine

4-Allyl-6-bromo-2-phenyl-4<i>H</i>-imidazo[4,5-<i>b</i>]pyridine monohydrate

6-Bromo-1,3-dimethyl-1<i>H</i>-imidazo[4,5-<i>b</i>]pyridin-2(3<i>H</i>)-one

1,3,3,5-Tetramethyl-1<i>H</i>-1,5-benzodiazepine-2,4(3<i>H</i>,5<i>H</i>)-dione

3-Benzoyl-1,5-dimethyl-1<i>H</i>-1,5-benzodiazepine-2,4(3<i>H</i>,5<i>H</i>)-\ dione

1,3-Dibenzyl-5-chloro-1<i>H</i>-benzimidazol-2(3<i>H</i>)-one

1,3-Bis[3-(1,3-dioxoisoindolin-2-yl)propyl]-1<i>H</i>- anthra[1,2-<i>d</i>]imidazole-2,6,11(3<i>H</i>)-trione

3-Hexadecyl-1,5-dimethyl-1<i>H</i>-1,5-benzodiazepine- 2,4(3<i>H</i>,5<i>H</i>)-dione

Di-<i>tert</i>-butyl 2,6,11-trioxo-2,3-dihydro-1<i>H</i>-anthra[1,2-<i>d</i>]imidazole-1,3-diacetate

3-{[3-(4-Methoxyphenyl)-4,5-dihydro-1,2-oxazol-5-yl]methyl}- 1,5-dimethyl-1<i>H</i>-1,5-benzodiazepine-2,4(3<i>H</i>,5<i>H</i>)-dione

5-Chloro-1-[(<i>E</i>)-3-(dimethylamino)acryloyl]-3-methyl-1<i>H</i>- benzimidazol-2(3<i>H</i>)-one--6-chloro-1-[(<i>E</i>)- 3-(dimethylamino)acryloyl]-3-methyl-1<i>H</i>-benzimidazol-2(3<i>H</i>)-one (4/1)

4-(1,3-Benzothiazol-2-yl)-1,5-dimethyl-2-phenyl-1<i>H</i>-pyrazol- 3(2<i>H</i>)-one

1,3-Diallyl-1<i>H</i>-anthra[1,2-<i>d</i>]imidazole-2,6,11(3<i>H</i>)-trione

1,3-Bis(naphthalen-2-ylmethyl)-1<i>H</i>-anthra[1,2-<i>d</i>]imidazole- 2,6,11(3<i>H</i>)-trione